Stereotaxis (STXS) Non-Current Debt (2010 - 2021)

Stereotaxis' (STXS) quarterly Non-Current Debt came in at $243617.0 in Q1 2021, down 74.97% on a QoQ basis from $973252.0 in Q4 2020.

Stereotaxis (STXS) Non-Current Debt (2010 - 2021) Analysis & Trends

Stereotaxis (STXS) has 9 years of Non-Current Debt data on file, last reported at $243617.0 in Q1 2021.

On a quarterly basis, Non-Current Debt changed N/A year-over-year to $243617.0 in Q1 2021; TTM through Mar 2021 was $243617.0, a N/A change from a year earlier, with the FY2020 full-year figure at $973252.0, changed N/A from the prior year.
Non-Current Debt for Q1 2021 stood at $243617.0, down from $973252.0 in the prior quarter.
Over the last five years, Non-Current Debt for STXS reached as high as $1.7 million in Q3 2020 and fell as low as $243617.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	4.16 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	14.71 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	12.50 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	404.17 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	202.90 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	1.86 Bn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	4.58 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	-
10	Stereotaxis	136.49 Mn	121.87 Mn	3.79 Mn	-

Download Data